“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” Anthony S. Fauci said alongside Trump at the White House on Wednesday. “That is really quite important.”The study showed that patients treated with remdesivir were ready to be discharged from the hospital within 11 days, on average, compared with an average of 15 days for patients who had received a placebo.While not a “knockout,” Fauci said that shows an important and promising avenue for further study. “What it has proven is that a drug can block this virus,” Fauci said.Remdesivir can have serious side effects, according to previous trial results, including loss of kidney function and declining blood pressure. Those symptoms are caused by severe cases of covid-19, as well, making it difficult to determine which problems were caused by the drug and which by the illness.The NIAID study is the most rigorous test to date of the potential treatment because it is a double-blind, placebo-controlled trial, the gold standard for seeing whether a drug is safe and effective.The study showed only a marginal benefit in the rate of death. Fauci said that a death rate of 8 percent for those taking the

Continue To Full Article